Literature DB >> 18154750

Characteristics of untreated AIDS-related cytomegalovirus retinitis. I. Findings before the era of highly active antiretroviral therapy (1988 to 1994).

Gary N Holland1, Jean D Vaudaux, Samuel M Jeng, Fei Yu, David T Goldenberg, Ina-Caren Folz, William G Cumberland, Colin A McCannel, Craig J Helm, W David Hardy.   

Abstract

PURPOSE: To identify factors related to variations in the appearance of untreated AIDS-related cytomegalovirus (CMV) retinitis in severely immunodeficient individuals before the availability of highly active antiretroviral therapy (HAART) and to draw inferences regarding early events in the natural history of CMV retinitis based on clinical findings.
DESIGN: Retrospective, observational case series.
METHODS: We evaluated a series of 100 adult patients with AIDS and newly diagnosed CMV retinitis before the HAART era who were not being treated with specific anti-CMV therapy. Demographic factors, ophthalmic findings, and the influence of drug therapy (zidovudine, acyclovir) on lesion characteristics were evaluated. Lesion border opacity was scored using a four-point scale of severity.
RESULTS: Lesions could be categorized by type (fulminant/edematous or indolent/granular) in only 66% of eyes. Severe lesion border opacity (4+) was related to presence of zone 1 lesions (P = .032) and greater extent of disease (P = .004). Acyclovir use was associated with less severe opacity (P = .029) and less zone 1 involvement (P = .016). Early lesions were adjacent to vessels in 73% of eyes; the fovea was involved in 13% of eyes.
CONCLUSIONS: Lesion location and drug use that affects virus activity may influence the severity of lesion border opacity, a measure that may be more useful than lesion type in future clinical studies of CMV retinitis. In contrast to earlier concepts, CMV retinitis does not seem to be a fovea-sparing disease. Findings in this study can serve as a reference for investigations into possible changes in CMV retinitis since the introduction of HAART.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18154750     DOI: 10.1016/j.ajo.2007.09.023

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  21 in total

1.  Cytomegalovirus retinitis and the acquired immunodeficiency syndrome--bench to bedside: LXVII Edward Jackson Memorial Lecture.

Authors:  Douglas A Jabs
Journal:  Am J Ophthalmol       Date:  2010-12-18       Impact factor: 5.258

2.  Course of cytomegalovirus retinitis in the era of highly active antiretroviral therapy: five-year outcomes.

Authors:  Douglas A Jabs; Alka Ahuja; Mark Van Natta; Alice Lyon; Sunil Srivastava; Sapna Gangaputra
Journal:  Ophthalmology       Date:  2010-07-29       Impact factor: 12.079

3.  Clinical features of newly diagnosed cytomegalovirus retinitis in northern Thailand.

Authors:  Somsanguan Ausayakhun; Jeremy D Keenan; Sakarin Ausayakhun; Choeng Jirawison; Claire M Khouri; Alison H Skalet; David Heiden; Gary N Holland; Todd P Margolis
Journal:  Am J Ophthalmol       Date:  2012-01-20       Impact factor: 5.258

4.  Development of cytomegalovirus retinitis after negative conversion of cytomegalovirus antigenemia due to systemic antiviral therapy.

Authors:  Kayo Suzuki; Kenichi Namba; Kazuomi Mizuuchi; Daiju Iwata; Takako Ito; Keitaro Hase; Nobuyoshi Kitaichi; Susumu Ishida
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2020-11-13       Impact factor: 3.117

5.  Comparative analysis of cytomegalovirus retinitis and microvascular retinopathy in patients with acquired immunodeficiency syndrome.

Authors:  Chao Chen; Chun-Gang Guo; Li Meng; Jing Yu; Lian-Yong Xie; Hong-Wei Dong; Wen-Bin Wei
Journal:  Int J Ophthalmol       Date:  2017-09-18       Impact factor: 1.779

6.  Accuracy and reliability of telemedicine for diagnosis of cytomegalovirus retinitis.

Authors:  Somsanguan Ausayakhun; Alison H Skalet; Choeng Jirawison; Sakarin Ausayakhun; Jeremy D Keenan; Claire Khouri; Khang Nguyen; Partho S Kalyani; David Heiden; Gary N Holland; Todd P Margolis
Journal:  Am J Ophthalmol       Date:  2011-09-08       Impact factor: 5.258

Review 7.  Viral posterior uveitis.

Authors:  Joanne H Lee; Aniruddha Agarwal; Padmamalini Mahendradas; Cecilia S Lee; Vishali Gupta; Carlos E Pavesio; Rupesh Agrawal
Journal:  Surv Ophthalmol       Date:  2016-12-22       Impact factor: 6.048

8.  CMV retinopathy in the antiretroviral therapy era: prevention, diagnosis, and management.

Authors:  Lisa Barrett; Sharon Walmsley
Journal:  Curr Infect Dis Rep       Date:  2012-08       Impact factor: 3.725

9.  Retinal detachment associated with AIDS-related cytomegalovirus retinitis: risk factors in a resource-limited setting.

Authors:  Michael Yen; Jenny Chen; Somsanguan Ausayakhun; Paradee Kunavisarut; Pornpattana Vichitvejpaisal; Sakarin Ausayakhun; Choeng Jirawison; Jessica Shantha; Gary N Holland; David Heiden; Todd P Margolis; Jeremy D Keenan
Journal:  Am J Ophthalmol       Date:  2014-10-22       Impact factor: 5.258

10.  Suppressor of Cytokine Signaling 1 (SOCS1) and SOCS3 Are Stimulated within the Eye during Experimental Murine Cytomegalovirus Retinitis in Mice with Retrovirus-Induced Immunosuppression.

Authors:  Hsin Chien; Christine I Alston; Richard D Dix
Journal:  J Virol       Date:  2018-08-29       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.